Novel interventions for the community care of late-life depression: A report by the Weill Cornell ALACRITY Center


Date of CE Release: 08/05/2021

Date of CE Expiration: 08/05/2022

Learner Notification

 

Faculty:

George Alexopoulos, MD
Weill Cornell Institute of Geriatric Psychiatry
 
Patricia Marino, PhD
Weill Cornell Medical College, Department of Psychiatry
 
Dimitris Kiosses, PhD
Weill Cornell Medicine
 
Jo Anne Sirey, PhD
Weill Cornell Medicine

 

Summary: Dr. Alexopoulos has conducted studies on treatments for patients with unmet needs, including low income depressed, disabled, home-bound patients, depressed stroke victims, depressed patients with severe chronic COPD, and depressed patients with executive dysfunction. He has been one of the first to use neurobiological models to streamline behavioral interventions so that they can be broadly used by community therapists.

 

UAN: JA4008163-9999-21-160-H04-P 
Activity Type: Knowledge Based

Objectives for Webinar:

1. Understand the role of neurobiological advances in the development of streamlined behavioral interventions
2. Learn how to work with community based services to develop user-based plans for implementing and testing streamlined interventions
3. Learn how mobile technology can be integrated in the care of depressed older adults
4. Familiarize themselves with principles of behavioral economics used in improving adherence to psychosocial interventions.

 

 Acknowledgement of Support

This webinar is supported in part by an unrestricted educational grant provided by the American Board of Psychiatry and Neurology (ABPN).

 

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for Geriatric Psychiatry.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physicians

Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

Nurses

Amedco LLC designates this activity for a maximum of1.0 ANCC contact hours.

 

Pharmacists

Amedco LLC designates this activity for a maximum of 1.0 knowledge-based CPE contact hours.

 

Psychologists

Amedco LLC designates this activity for a maximum of 1.0 psychologist contact hours. 

 

Click here for list of state boards accept courses from APA providers for Counselors, MFTs, Addictions Professionals, and Social Workers.

 

Social Workers

As a Jointly Accredited Organization, Amedco is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Amedco maintains responsibility for this course. Social workers completing this course receive 1.0 GENERAL continuing education credits.

 

Click here for list of state boards accept courses offering ASWB ACE credit for Social Workers, Counselors, MFTs, and Addictions Professionals.

 

Disclosure of Relevant Financial Relationships:

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

 

All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no relevant financial relationships.

 

George Alexopoulos
Speakers Bureau - Otsuka Pharmaceutical, Sunovion Pharmaceutical, Allergan
Research Grant Overall Principal Investigator - NIMH Grants
Scientific/Medical Advisory Board Member - Janssen and Otsuka
Patricia Marino Other - NIMH Grants
Dimitris Kiosses Other - NIMH Grants
Jo Anne Sirey No relevant financial relationship exists

 

 

Click here to complete the Webinar Post Test and CE Evaluation  


Back to webinar listing